Anaphylaxis Is Pharmacovigilance Focus As Moderna Vaccine Distribution Begins

 
• By Cathy Kelly
CDC Adverse Event Mitigation Strategy Addresses Anaphylaxis

More from Vaccines

More from Pink Sheet